Regent Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.64M | Sell |
6,608
-40
| -0.6% | -$21.2K | 0.97% | 26 |
|
|
2022
Q3 | $3.37M | Buy |
6,648
+50
| +0.8% | +$28K | 0.98% | 25 |
|
|
2022
Q2 | $3.58M | Sell |
6,598
-127
| -2% | -$69.9K | 1% | 23 |
|
|
2022
Q1 | $3.97M | Sell |
6,725
-50
| -0.7% | -$28.7K | 0.92% | 27 |
|
|
2021
Q4 | $4.52M | Sell |
6,775
-50
| -0.7% | -$31.2K | 0.99% | 22 |
|
|
2021
Q3 | $3.9M | Sell |
6,825
-120
| -2% | -$65.9K | 0.93% | 25 |
|
|
2021
Q2 | $3.5M | Sell |
6,945
-77
| -1% | -$36.3K | 0.82% | 31 |
|
|
2021
Q1 | $3.21M | Buy |
7,022
+30
| +0.4% | +$14.3K | 0.81% | 33 |
|
|
2020
Q4 | $3.26M | Sell |
6,992
-860
| -11% | -$403K | 0.9% | 30 |
|
|
2020
Q3 | $3.47M | Sell |
7,852
-70
| -0.9% | -$28.9K | 1.07% | 21 |
|
|
2020
Q2 | $2.87M | Sell |
7,922
-155
| -2% | -$52K | 0.95% | 27 |
|
|
2020
Q1 | $2.29M | Sell |
8,077
-68
| -0.8% | -$21.4K | 0.94% | 30 |
|
|
2019
Q4 | $2.65M | Buy |
8,145
+65
| +0.8% | +$19.7K | 0.81% | 33 |
|
|
2019
Q3 | $2.35M | Sell |
8,080
-5
| -0.1% | -$1.43K | 0.77% | 35 |
|
|
2019
Q2 | $2.37M | Sell |
8,085
-5
| -0.1% | -$1.38K | 0.77% | 39 |
|
|
2019
Q1 | $2.21M | Sell |
8,090
-85
| -1% | -$21.2K | 0.74% | 44 |
|
|
2018
Q4 | $1.83M | Buy |
8,175
+190
| +2% | +$44.6K | 0.69% | 49 |
|
|
2018
Q3 | $1.95M | Sell |
7,985
-700
| -8% | -$161K | 0.61% | 51 |
|
|
2018
Q2 | $1.8M | Sell |
8,685
-235
| -3% | -$49.9K | 0.6% | 51 |
|
|
2018
Q1 | $1.84M | Buy |
8,920
+60
| +0.7% | +$12.6K | 0.62% | 51 |
|
|
2017
Q4 | $1.68M | Buy |
8,860
+190
| +2% | +$36.4K | 0.55% | 57 |
|
|
2017
Q3 | $1.64M | Sell |
8,670
-340
| -4% | -$61.6K | 0.55% | 54 |
|
|
2017
Q2 | $1.57M | Buy |
9,010
+30
| +0.3% | +$5.04K | 0.55% | 56 |
|
|
2017
Q1 | $1.38M | Sell |
8,980
-273
| -3% | -$41.7K | 0.52% | 63 |
|
|
2016
Q4 | $1.31M | Buy |
9,253
+75
| +0.8% | +$11.1K | 0.67% | 40 |
|
|
2016
Q3 | $1.46M | Hold |
9,178
| – | – | 0.76% | 35 |
|
|
2016
Q2 | $1.36M | Sell |
9,178
-50
| -0.5% | -$7.38K | 0.74% | 40 |
|
|
2016
Q1 | $1.31M | Sell |
9,228
-337
| -4% | -$45.2K | 0.73% | 38 |
|
|
2015
Q4 | $1.36M | Sell |
9,565
-320
| -3% | -$42.7K | 0.73% | 41 |
|
|
2015
Q3 | $1.21M | Buy |
9,885
+40
| +0.4% | +$5.21K | 0.67% | 43 |
|
|
2015
Q2 | $1.28M | Hold |
9,845
| – | – | 0.64% | 43 |
|
|
2015
Q1 | $1.32M | Sell |
9,845
-100
| -1% | -$12.9K | 0.67% | 43 |
|
|
2014
Q4 | $1.25M | Buy |
9,945
+220
| +2% | +$26.8K | 0.64% | 45 |
|
|
2014
Q3 | $1.18M | Buy |
9,725
+460
| +5% | +$55.9K | 0.61% | 52 |
|
|
2014
Q2 | $1.09M | Sell |
9,265
-85
| -0.9% | -$10K | 0.54% | 59 |
|
|
2014
Q1 | $1.12M | Sell |
9,350
-1,200
| -11% | -$143K | 0.59% | 59 |
|
|
2013
Q4 | $1.18M | Sell |
10,550
-3,300
| -24% | -$328K | 0.66% | 50 |
|
|
2013
Q3 | $1.28M | Sell |
13,850
-165
| -1% | -$14.9K | 0.84% | 38 |
|
|
2013
Q2 | $1.19M | Buy |
+14,015
| New | +$1.17M | 0.91% | 35 |
|
Other funds holding TMO
Regent Investment Management's TMO Position: Q4 2022 in Review
Regent Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.6% in Q4 2022, selling an estimated $21.2K and leaving 6,608 shares worth $3.64M. The position accounts for 0.97% of the portfolio, ranked #26.
Regent Investment Management first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $4.52M in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.
- Regent Investment Management held 6,608 shares of Thermo Fisher Scientific worth $3.64M as of Q4 2022.
- Regent Investment Management sold 40 Thermo Fisher Scientific shares in Q4 2022, an estimated $21.2K.
- Thermo Fisher Scientific made up 0.97% of Regent Investment Management's portfolio in Q4 2022, its #26 holding.
- Regent Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Regent Investment Management's Thermo Fisher Scientific position peaked at $4.52M in Q4 2021.
- 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.